Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BK03	FLORIANCE 25	G	Empagliflozin - 25mg	25mg	Tablet, film coated	1,791,790 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
L02BA03	FULVESTRANT ARROW	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	12,644,009 L.L
L02BA03	FUXRAN	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	39,382,304 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	1,791,342 L.L
C03CA01	FUROSEMIDE S.A.L.F.	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	919,188 L.L
L02BA03	FULVESTRANT EVER PHARMA	G	Fulvestrant - 250mg/5ml	250mg	Injectable solution	29,905,966 L.L
P01AB01	FLAGYL	B	Metronidazole - 250mg	250mg	Tablet, film coated	176,043 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 250mcg/actutaion	250mcg/actutaion	Inhalation suspension	1,484,946 L.L
B03AA02	FERRATE	G	Ferrous fumarate - 20mg/ml (iron element)	20mg/ml	Suspension	667,890 L.L
C03CA01	FRURETIC	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	2,600,655 L.L
C03CA01	FUROLIX	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,612,611 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	451,531 L.L
C03CA01	FUROSEMIDE SALF	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	216,359 L.L
A02BA03	FAMODAR 20	G	Famotidine - 20mg	20mg	Tablet, film coated	552,319 L.L
A02BA03	FAMONOR	G	Famotidine - 20mg	20mg	Tablet, film coated	220,390 L.L
N06AB03	FLUOXETINA-Key	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	448,843 L.L
N06AB03	FLUOXETINE BIOGARAN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	239,204 L.L
N06AB03	FLUOXONE DIVULE	G	Fluoxetine (HCl) - 20mg	20mg	Tablet, coated	627,574 L.L
N06AB03	FULSAC	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	435,405 L.L
N06AB03	FLUTIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	362,837 L.L
H05AA02	FORTEO	BioTech	Teriparatide - 250mcg/ml	20mcg/80mcl	Injectable solution	24,834,241 L.L
J02AC01	FLUCONAZOLE PANPHARMA	G	Fluconazole - 200mg/100ml	200mg/100ml	Injectable solution	11,256,652 L.L
A07AX03	FUROXYL	G	Nifuroxazide - 200mg	200mg	Capsule	366,037 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	682,160 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	9,355,300 L.L
C10AB05	FENOGAL	G	Fenofibrate micronised - 200mg	200mg	Capsule, micronized	392,402 L.L
J01DD08	FIXIM	G	Cefixime (trihydrate) - 200mg	200mg	Capsule	890,968 L.L
L02BG04	FEMARA	B	Letrozole - 2.5mg	2.5mg	Tablet, film coated	3,433,518 L.L